p54

I've updated your research topic understanding. You can refine it further or move on to search.

Animal models, primarily comprising Nono gene-trap mice and Drosophila nonA mutants, have established the p54nrb (NONO) protein as a pleiotropic regulator of neurodevelopment, circadian rhythm, DNA repair, and tumorigenesis (Direct, High; PMID: 26571461, PMID: 30057203). These models have been instrumental in characterizing human pathologies such as X-linked syndromic intellectual developmental disorder-34 (MRXS34) and various aggressive malignancies (Direct, High; PMID: 27329731, PMID: 34079086).

Neurodevelopmental and Cognitive Models

• Murine Nono Gene-Trap (gt) Model: These mice exhibit a distinct physical gestalt including a flattened nose and macrocephaly, mimicking human MRXS34 patients (Direct, High; PMID: 26571461).
  • Behavioral Phenotype: Mutant mice show impaired spatial memory in the Morris water maze and significant anxiety phenotypes (Direct, High; PMID: 26571461).
  • Cellular and Synaptic Defects: Brain analysis reveals a smaller cerebellum and reduced density of inhibitory synaptic markers (gephyrin and GABA$_A$R $\alpha$2) in the hippocampus (Direct, High; PMID: 26571461).
• Stem Cell Models: NONO-deficient mouse embryonic stem cells (mESCs) show a global reduction in H3K36me2-decorated active chromatin and are unable to differentiate normally into neural progenitor cells (NPCs) (Direct, High; PMID: 40913772).
• Drosophila nonA Ortholog Models: Mutants show defects in vision, courtship song, and survival (Direct, High; PMID: 8778301). The nonA diss allele, caused by an R548C mutation in the coiled-coil domain, leads to neurological phenotypes associated with constitutive polymerization (Derived, High; PMID: 8778301, PMID: 39698821).

DNA Damage Response and Reproductive Models

• Testis DNA Damage Model: While Nono gt mice have nearly normal seminiferous tubule histology under basal conditions, they exhibit extreme hypersensitivity to ionizing radiation (Direct, High; PMID: 28209515).
  • Mechanisms: NONO is essential for Sertoli cell survival and maintenance of the blood-testis barrier after DNA double-strand breaks (DSBs). Unlike in other tissues, the loss of NONO in the testes is not compensated for by its paralog PSPC1 (Direct, High; PMID: 28209515).
• Lung Cancer DNA Stability Models: In murine non-small-cell lung cancer (NSCLC) cells, the deletion of NONO causes genome instability and hypersensitivity to damaging agents like etoposide and bleomycin by failing to induce the repair factor Gadd45b (Direct, High; PMID: 38843934).
• ASO Toxicity Models: Acute hepatotoxicity in mice treated with 2'-fluoro-modified oligonucleotides is driven by the rapid degradation of NONO and its partner PSF, leading to accumulated DSBs and liver necrosis (Direct, High; PMID: 29390093).

Oncogenic and Metabolic Models

• Hepatocellular Carcinoma (HCC) Models:
  • Tumorigenesis: NONO knockout in HCC cell lines significantly inhibits tumor growth, angiogenesis, and glycolysis in mouse subcutaneous xenografts (Direct, High; PMID: 34079086).
  • Mechanism: NONO acts as a transcriptional co-activator for HIF-1$\alpha$ and HIF-2$\alpha$, facilitating the expression of genes like VEGFA and GLUT1 (Direct, High; PMID: 34079086).
• Breast and Ovarian Cancer Models:
  • Triple-Negative Breast Cancer (TNBC): NONO promotes tumorigenesis by stabilizing nuclear EGFR and STAT3 (Direct, High; PMID: 35013116, DOI: 10.1038/s41419-021-04488-9).
  • Ovarian Cancer: NONO interacts with POLR2A to drive GDF15 transcription; this complex is disrupted by the tumor-suppressive circular RNA circMETTL6 (Direct, High; PMID: 39899667).
• Glioblastoma Models: NONO is required for efficient mRNA splicing of PRMT1 and GPX1; its depletion leads to intron retention, redox imbalance, and inhibited cell invasion (Direct, High; PMID: 38303029, PMID: 39183343).

Circadian Rhythm Models

• Drosophila Locomotor Models: RNAi-mediated knockdown of nonA in the central circadian neurons of flies results in a lengthened free-run period and a complete absence of evening activity anticipation (Direct, High; PMID: 30057203).
• Mechanism: nonA interacts with the clock protein CLK and is required for the proper expression of Complexin (cpx) to regulate neuropeptide release (Direct, High; PMID: 30057203).
• Mammalian Cell Models: Patient-derived fibroblasts with NONO mutations show a reduced amplitude of circadian oscillations (Direct, High; PMID: 26571461).

Associated Human Pathologies

• MRXS34 Syndrome: Caused by hemizygous loss-of-function mutations. Features include slender build, macrocephaly, thick corpus callosum, intellectual disability, and left ventricular non-compaction cardiomyopathy (Direct, High; PMID: 27329731).
• Congenital Defects: Fetal cases have identified NONO mutations associated with hypoplastic left heart syndrome (HLHS) and other structural heart anomalies (Direct, High; PMID: 33304389).
• Skeletal and Hematological Issues: Recent reports have expanded the spectrum to include recurrent fractures from non-ossifying fibromas and congenital thrombocytopenia (Direct, High; PMID: 37533431).

What molecular mechanisms explain the failure of neural progenitor cell differentiation in NONO-deficient mESCs?

How do specific mutations in the NONO RRM and coiled-coil domains selectively affect vision and courtship behaviors in animal models?

What is the role of NONO in mediating therapeutic resistance to sorafenib and temozolomide across the cited cancer models?

Unverified Citations

The following sources failed to support their assigned claims after 3 verification rounds designed to ensure only high-confidence, relevant references are retained:

• PMID:25855809 — ** ASO Toxicity Models: Acute hepatotoxicity in mice treated with 2'-fluoro-modified oligonucleotides is driven by ...*
  Failed: disease — Paper 2 identifies rapid degradation of P54nrb and PSF in HeLa, A431, and mouse MHT cells in vitro, but it does not perform mouse liver (hepatotoxicity) or liver necrosis experiments in vivo.
• PMID:26571461 — Features include slender build, macrocephaly, thick corpus callosum, intellectual disability, and left ventricular non-c...
  Failed: conclusion — Paper 3 describes the patients as macrocephalic but does not document left ventricular non-compaction cardiomyopathy (LVNC) in the clinical report section.

Hypothesis 1

In MRXS34 syndrome, neurodevelopmental failure results from transcription-replication conflicts at synaptic gene loci, where accumulated R-loops competitively inhibit the NONO-mediated allosteric stimulation of NSD1, leading to localized depletion of H3K36me2 active chromatin and transcriptional silencing of inhibitory synapse components such as Gabra2.

Mechanistic rationale

• NONO allosterically stimulates the histone methyltransferase NSD1 through its PWWP2 domain to catalyze H3K36me2 deposition, a prerequisite for neural progenitor cell differentiation. (Direct, High; PMID: 40913772)
• The deficiency of NONO leads to the accumulation of unscheduled R-loops across the genome, resulting in increased DNA damage and genomic instability. (Indirect, Low; PMID: 40352720)
• Synaptic transcript abundance, specifically the GABA receptor alpha-2 subunit (Gabra2), is significantly reduced in NONO-deficient mouse brains and patient cells, causing inhibitory synaptic defects. (Direct, High; PMID: 26571461)
• NONO binds to RNA/DNA hybrids (R-loops) via its RRM1 domain during stress, a mechanism that can detain transcripts in the nucleolus or regulate chromatin occupancy at protein-coding promoters. (Derived, Medium; PMID: 38224452, PMID: 40352720)
• The structural plasticity of the NONO coiled-coil domain allows it to bridge nucleic acid binding with the recruitment of transcriptional co-activators and chromatin modifiers. (Derived, Medium; PMID: 40574713, PMID: 39698821, PMID: 35013116)

Predictions

• Genome-wide mapping in NONO-deficient neural progenitor cells will reveal a significant increase in R-loop occupancy specifically at the Gabra2 gene body and other synaptic loci that are downregulated in MRXS34.
• H3K36me2 active chromatin marks will be selectively lost at the Gabra2 locus in NONO-deficient cells, while repressive marks like H3K27me3 will increase due to biochemical antagonism.
• Ectopic expression of RNase H1 to resolve R-loops will rescue localized H3K36me2 levels and partially restore Gabra2 expression and NPC differentiation in NONO-deficient models. (Derived, Medium; PMID: 40913772, PMID: 40352720, PMID: 38224452)

Study design

Using mouse embryonic stem cells (mESCs) as a model, generate NONO CRISPR knockout lines and differentiate them into neural progenitor cells (NPCs). Perform integrated genomic profiling including DRIP-seq (for R-loops), ChIP-seq (for H3K36me2, H3K27me3, and NSD1 occupancy), and RNA-seq. Apply these methods before and after treatment with an R-loop resolving factor (lentiviral RNase H1) or an NSD1-PWWP2 competitive inhibitor. (Derived, Medium; PMID: 40913772, PMID: 40352720, PMID: 26571461)

Confounders & controls

• Compensatory upregulation of PSPC1 or SFPQ in some tissues may mask the severity of the differentiation defect, although evidence suggests this does not restore behavioral/synaptic function. (Derived, Medium; PMID: 26571461, PMID: 28209515)
• Circadian oscillation of R-loop accumulation may confound single-timepoint snapshots; therefore, samples must be synchronized or collected at multiple circadian times. (Derived, Medium; PMID: 40352720)

Risks/limitations

• NSD1 is one of five H3K36 methyltransferases; other family members (NSD2/3) might maintain global H3K36me2 levels despite localized defects at synaptic loci. (Direct, High; PMID: 40913772)
• NEAT1-mediated paraspeckle formation, which is absent in ESCs but induced upon differentiation, may sequester released NONO and complicate the measurement of its chromatin-bound activity. (Derived, Medium; PMID: 28288210, PMID: 36546462, PMID: 40913772)

Falsification criteria

• The hypothesis will be falsified if R-loop resolution by RNase H1 does not restore H3K36me2 levels at synaptic loci in NONO-deficient NPCs, or if localized H3K36me2 depletion is observed to be independent of R-loop occupancy.

Unverified Citations

The following sources failed to support their assigned claims after 3 verification rounds designed to ensure only high-confidence, relevant references are retained:

• PMID: 40352720 — Genome-wide mapping in NONO-deficient neural progenitor cells will reveal a significant increase in R-loop occupancy spe...
  Failed: entities,conclusion — The paper maps R-loops genome-wide in fibroblasts but does not mention the Gabra2 gene or synaptic loci.
• PMID: 26571461 — Genome-wide mapping in NONO-deficient neural progenitor cells will reveal a significant increase in R-loop occupancy spe...
  Failed: mechanism,conclusion — The paper characterizes Gabra2 reduction but does not measure or mention R-loops.
• PMID: 40913772 — H3K36me2 active chromatin marks will be selectively lost at the Gabra2 locus in NONO-deficient cells, while repressive m...
  Failed: entities,conclusion — While the paper describes global H3K36me2 loss and H3K27me3 antagonism in NONO-deficient cells, it does not mention or test the Gabra2 locus.
• PMID: 26571461 — H3K36me2 active chromatin marks will be selectively lost at the Gabra2 locus in NONO-deficient cells, while repressive m...
  Failed: mechanism,conclusion — The paper establishes Gabra2 reduction in NONO-deficient mice but contains no data regarding H3K36me2 or H3K27me3 histone marks.
• PMID: 30057203 — Circadian oscillation of R-loop accumulation may confound single-timepoint snapshots; therefore, samples must be synchro...
  Failed: entities,conclusion — The paper discusses circadian regulation of gene expression and behavior but does not mention or measure R-loops.
• PMID: 40913772 — The hypothesis will be falsified if R-loop resolution by RNase H1 does not restore H3K36me2 levels at synaptic loci in N...
  Failed: entities,conclusion — The paper discusses H3K36me2 and NONO, but does not use RNase H1 to attempt restoration of histone marks or mention the Gabra2 locus.
• PMID: 40352720 — The hypothesis will be falsified if R-loop resolution by RNase H1 does not restore H3K36me2 levels at synaptic loci in N...
  Failed: entities,conclusion — The paper uses RNase H1 to show R-loop resolution reduces DNA damage markers, but does not measure H3K36me2 restoration or mention the Gabra2 gene.

Methodology

Design

The methodology employs a longitudinal, comparative mapping design across four primary experimental groups: wild-type (WT) mouse embryonic stem cells (mESCs), NONO-knockout (NONO-KO) mESCs, and their corresponding differentiated neural progenitor cell (NPC) lineages. To determine the causal role of DNA-RNA hybrids, a secondary rescue arm utilizes lentiviral overexpression of RNase H1 in NONO-KO cells during the NPC differentiation window. Differentiation proceeds via embryoid body (EB) formation for 8 days, followed by retinoic acid (RA) induction and adherent culture specify neural specification. Quantitative genomic profiling is conducted at day 0 (mESC) and day 6 (NPC) post-induction. (Derived; PMID: 40913772, PMID: 40352720, PMID: 26571461)

Model/system (justification)

Mouse E14Tg2a embryonic stem cells are selected because they are a validated system for modeling the neurodevelopmental specifiers of MRXS34 syndrome and studying the biochemical interaction between NSD1 and NONO. These cells lack baseline NEAT1 expression and mature paraspeckles, providing a clean background to observe NONO-chromatin interactions and H3K36me2 deposition prior to and during lineage commitment. (Direct; PMID: 40913772)

Interventions & assays

The study uses CRISPR/Cas9-mediated gene editing to generate homozygous NONO-KO E14 mESC lines. Integrated genomic readouts include: (1) DRIP-seq using the S9.6 antibody to map R-loop occupancy genome-wide and specifically at synaptic gene bodies; (2) Quantitative ChIP-seq with Drosophila chromatin spike-in for H3K36me2, H3K27me3, and endogenous NSD1 occupancy levels; and (3) strand-specific RNA-seq to measure mature and nascent Gabra2 transcript abundance. Additionally, in vitro histone methyltransferase (HMT) assays will test the ability of synthetic Gabra2 R-loop chimeras to competitively inhibit NONO-mediated stimulation of full-length NSD1. (Derived; PMID: 40913772, PMID: 40352720, PMID: 38224452, PMID: 26571461)

Controls & replicates

Controls include WT mESCs and NONO-KO cells rescued with full-length HA-tagged NONO or a non-binding RRM1 mutant. Negative controls for genomic assays include in vitro RNase H1 digestion of isolated DNA before S9.6 immunoprecipitation (DRIP-seq) and IgG isotype controls for ChIP. Positive controls for NPC specification include Nestin and SOX2 immunostaining. All sequencing and differentiation assays are performed in triplicate technical replicates across five biological batches. (Derived; PMID: 40913772, PMID: 40352720, PMID: 26571461)

Endpoints & Go/No-Go

The primary endpoint is the successful restoration of H3K36me2 occupancy and Gabra2 mRNA levels (TPM) in NONO-KO NPCs following RNase H1 treatment. A Go decision is warranted if RNase H1 reduces R-loop occupancy at the Gabra2 locus by >50% and concurrently restores H3K36me2 marks. A No-Go decision results if H3K36me2 depletion persists in NONO-KO cells despite effective R-loop resolution, suggesting R-loops are a secondary consequence rather than a competitive inhibitor. (Derived; PMID: 40913772, PMID: 40352720, PMID: 26571461)

Statistical analysis

Genome-wide peak calling is performed using SICER2 and MACS2, with normalization provided by Drosophila chromatin spike-ins. Differential gene expression (RNA-seq) is calculated via DESeq2 with FDR < 0.01. Correlation between R-loop gain and H3K36me2 loss is assessed using Pearson's coefficients. Morphological NPC differentiation percentages are compared via one-way ANOVA followed by Tukey's post-hoc test to evaluate rescue effects across multi-arm interventions. (Direct; PMID: 40913772)

Confounders & handling

To mitigate compensatory upregulation of paralogs PSPC1 or SFPQ, protein levels are monitored via western blog; if significant compensation occurs, dual knockdown strategies will be implemented. Potential circadian oscillation of R-loop accumulation is addressed by synchronizing mESCs/NPCs and harvesting at consistent intervals. Off-target effects of CRISPR are mitigated by screening multiple guide RNAs and using a matched isogenic control rescued with the WT gene. (Derived; PMID: 26571461, PMID: 40352720, PMID: 39698821)

Risks/limitations

A primary risk is the redundancy of other H3K36 methyltransferases (NSD2/3, SETD2) which may mask global H3K36me2 reductions. Additionally, the structural plasticity of the NONO coiled-coil domain and its role in liquid-liquid phase separation (LLPS) may sequester proteins in paraspeckles upon differentiation, confounding chromatin-bound NONO measurements. We will employ cell fractionation to isolate chromatin-bound versus nucleoplasmic/paraspeckle-associated fractions. (Derived; PMID: 40913772, PMID: 40574713, PMID: 36546462)

Bioethics & QC

Cell line authentication is verified via STR profiling, and cultures are confirmed mycoplasma-negative every three months. Standard Operating Procedures (SOPs) for mESC maintenance adhere to Institutional Biosafety Committee (IBC) guidelines. All sequencing datasets will be deposited in the European Nucleotide Archive (ENA), and raw data will be stored in versioned electronic lab notebooks to ensure traceability and reproducibility. (Derived; PMID: 40352720, PMID: 36546462)

Unverified Citations

The following sources failed to support their assigned claims after 3 verification rounds designed to ensure only high-confidence, relevant references are retained:

• PMID: 26571461 — Mouse E14Tg2a embryonic stem cells are selected because they are a validated system for modeling the neurodevelopmental ...
  Failed: conclusion — The paper does not mention NEAT1 expression levels in stem cells, mature paraspeckles, H3K36me2 deposition, or the NSD1 interaction.
• PMID: 40913772 — To achieve a statistical power of at least 80% with an alpha of 0.05, five biological replicates per group are required....
  Failed: conclusion — The paper uses the NPC differentiation assay but does not mention Gabra2 transcript levels, RNase H1 interventions, or the specific 1.5-fold/30% effect sizes.
  Possible alternatives (unverified): PMID:28288210 (51% topic match); PMID:38224452 (47% topic match)
• PMID: 26571461 — To achieve a statistical power of at least 80% with an alpha of 0.05, five biological replicates per group are required....
  Failed: entities,conclusion — The paper identifies the reduction in Gabra2 but does not study NPC differentiation, RNase H1, or provide the statistical power estimates/effect sizes mentioned.
  Possible alternatives (unverified): PMID:28288210 (51% topic match); PMID:38224452 (47% topic match)
• PMID: 40352720 — Genome-wide peak calling is performed using SICER2 and MACS2, with normalization provided by Drosophila chromatin spike-...
  Failed: entities,conclusion — The paper uses MACS2 and EdgeR for R-loop analysis but does not mention SICER2, H3K36me2 loss, or NPC differentiation rescue effects.